U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Oxazolidinone penetration enhancing compounds

Patent 4960771 Issued on October 2, 1990. Estimated Expiration Date: Icon_subject July 12, 2008. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

2909467

Penetration enhancers for transdermal drug delivery of systemic agents
Patent #: 4405616
Issued on: 09/20/1983
Inventor: Rajadhyaksha

Vehicle composition containing 1-substituted azacyclohexan-2-ones
Patent #: 4423040
Issued on: 12/27/1983
Inventor: Rajadhyaksha

Base composition for medicament and pharmaceutical composition for external medication Patent #: 4594243
Issued on: 06/10/1986
Inventor: Satoh ,   et al.

Inventor

Application

No. 218316 filed on 07/12/1988

US Classes:

514/228.8, Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.)514/376, Chalcogen bonded directly to ring carbon of the oxazole ring514/452, Plural ring oxygens in the hetero ring514/467, Only two ring oxygens in the hetero ring which is not a polycyclo ring system (e.g., dioxolane, etc.)514/470, Chalcogen or nitrogen bonded directly to the hetero ring514/947, Topical application544/318, Additional chalcogen attached directly or indirectly to the diazine ring by nonionic bonding548/229, Chalcogen bonded directly at 2-position of the oxazole ring548/230Nitrogen, halogen, or -C(=X)-, wherein X is chalcogen, attached directly to the oxazole ring by nonionic bonding

Examiners

Primary: Schenkman, Leonard

Attorney, Agent or Firm

International Classes

A61K 031/42
A61K 031/535

Abstract

Compositions for carrying physiologically active agents through body membranes having the structural formula I: ##STR1## where: R=H, Alkyl group containing from 1-18 carbon atoms, cycloalkyl, aryl, aralkyl, alkoxy, hydroxyalkyl, alkoyloxyalkyl, acyloxyalkyl and alkoxyalkyl;X=O and NR1, where R1 is selected from H, alkyl, aralkyl acyl group containing from 1-18 carbon atoms, cycloalkyl, hydroxyalkyl, alkoyloxyalkyl acyloxyalkyl and alkoxyalkyl;Y=O and NR2, where R2 is selected from H, alkyl, aralkyl, cycloalkyl, acyl group containing from 1-18 carbon atoms, hydroxyalkyl, alkoyloxyalkyl, acyloxyalkyl and alkoxyalkyl;m=2-4; andn=0-4,are disclosed.

Other References

  • Catalog Handbook of Fine Chemicals 1988-1989, p. 609, Aldrich Chemical Company, Milwaukee, Wisconsin
  • Stoughton et al., pp. 737-739, Development Drug and Industrial Pharmacy, 9(4), 725-744 (1983)
  • Woodford and Barry, pp. 170-172, J. Toxicol.-Cut. & Ocular Toxicol. 5(3), 167-177 (1986)
  • Gummer, P. 566 in Percutaneous Absorption Mechanism-Methodolgy--Drug Delivery, Ed. Bronaugh and Maibach, chapter 43, 561-571, Marcel Dekker, 1985
  • Transdermal Delivery of Drugs, p. 76, vol. II, Ed. Kydonieus and Berner, CRC Press Inc., Boca Raton, Florida, 1987
  • Barry in Dermatological Formulations, Barry, pp. 160-172, Marcel Dekker, New York, 198
PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
 
Sign InRegister
Username  
Password   
forgot password?